Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

INTRODUCTION: Brain metastases (BM) are common in advanced non-small cell lung cancer (NSCLC), and the prognosis is poor with few therapeutic options. This study evaluated the efficacy of three epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) in preventing and treating BM in p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Su, Po-Lan, Wu, Yi-Lin, Chang, Wei-Yuan, Ho, Chung-Liang, Tseng, Yau-Lin, Lai, Wu-Wei, Su, Wu-Chou, Lin, Chien-Chung, Yang, Szu-Chun
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156208/
https://ncbi.nlm.nih.gov/pubmed/30263066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918797589
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky